Clinical Features of Peripheral Primitive Neuroectodermal Tumors:a Report of 15 Cases

FENG Yi,ZHOU Yuhong
DOI: https://doi.org/10.3969/j.issn.1008-6358.2012.05.034
2012-01-01
Abstract:Objective:To investigate the clinical features,diagnosis,treatment and prognosis of peripheral primitive neuroectodermal tumor(pPNET).Methods:From June 2006 to May 2011,15 cases of pPNET have been reviewed.There were 7 males and 8 females,with a median age of 23 years(ranged from 11 to 55).Six cases occurred primarily in bone,4 cases in soft tissues,one case in chest wall(Askin's),one case in mediastinum,one case in retroperitoneum,one case in kidney and one case in scalp.All the cases underwent multimodal therapy(surgery/radiotherapy/chemotherapy).The chemotherapy regimens included three drugs combination(ifosfamide or cyclophosphamide+adriamycin or epirubicin +cisplatin,ifosfamide + adriamycin +dacarbazine,ifosfamide or cyclophosphamide+ adriamycin+vincristine)or two drugs combination(ifosfamide+etoposide,ifosfamide+ adriamycin).Results: As far as June 2011,none of the 5 cases undergoing adjuvant chemotherapy had recurrence(the follow-up time was 6-42 months,the median follow-up time was 21 months).Among 10 cases undergoing palliative chemo-therapy,one case was complete response(CR),3 cases were partial response(PR),3 cases were stable disease(SD),3 cases were progressive disease(PD) and two of them died.Overall reaction ratio(ORR) was 70%.The time to progression(TTP) of three progressed patients were 2.4,7 and 8 months.The median follow-up time was 21 months.Only 2 patients died because of disease progression.The median overall survival had not been reached.Conclusions: pPNET is a type of high malignant and heterogeneous tumor.The diagnosis of pPNET depends on pathology.Reasonable multimodal therapeutic regimens can prolong the survival.Alternative administration of CAV/IE for pPNET maybe a promising and safe chemotherapy regimen.
What problem does this paper attempt to address?